Market Insights
Snoring is a very common problem, irrespective of gender, due to airway blockage. Snoring may be a sign or symptom of more severe obstructive sleep apnea. Airway obstruction is caused by a variety of factors, such as improper mouth anatomy, tonsil enlargement, or nasal congestion, which narrow the passage of airflow and almost stop breathing. Aside from the ones mentioned, other risk factors for snoring include obesity, alcohol consumption, allergies, smoking, and the use of sedatives or antidepressant drugs.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
As per the study by the World Health Organization, approximately 100,000,000 people are estimated to suffer from snoring problems, and this issue is proportionate to age and is maximally found in the age group of 55–60 years. According to the American Sleep Association, 50-70 million people in the United States have a sleep disorder, and 48% of those have been reported for snoring. The treatment of the increasing burden of snoring problems is needed to prevent the risk of heart disease, diabetes, obesity, gastroesophageal reflux disease, mental health issues due to sleep deprivation, and other complications.
The treatment of snoring can be done non-invasively using anti-snoring devices or through surgical interventions, depending on the severity. After getting diagnosed with snoring problems, either drugs or anti-snoring devices like mouthpieces, implants, or Continuous Positive Airway Pressure (CPAP) are prescribed. Sometimes the patients need to undergo a traditional or laser surgical procedure to completely uproot the cause of their snoring issues.
The growing aging population is the key driver of the anti-snoring device and snoring surgery markets. The increasing trend of alcohol consumption and smoking also fuels the growth of the anti-snoring device and snoring surgery markets. Constantly changing lifestyles and diets are the primary cause of the world’s growing obesity problem, which in turn aids in the growth of the anti-snoring device and snoring surgery markets. The reimbursement policies for oral appliances as well as surgeries propel the growth of the anti-snoring device and snoring surgery markets. However, the cost associated with the surgical procedure and anti-snoring devices may pose some challenges to the growth of the anti-snoring device and snoring surgery markets. The lack of public awareness about snoring treatment and the use of anti-snoring devices may act as a restraint on the anti-snoring device and snoring surgery markets in developing regions around the world.
The purpose of this research study titled “Anti-snoring device and snoring surgery market: growth, future prospects, and competitive analysis, 2017–2025” is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global anti-snoring device and snoring surgery market. This report presents and analyses the major trends prevalent in the global anti-snoring device and snoring surgery market and the market size and forecast.
This report categorizes the global anti-snoring device and snoring surgery market in terms of device type, surgery type, and geographical distribution.
Depending on the device types, the anti-snoring device and snoring surgery market are classified as follows:
- Oral Appliances
- Tongue-retentive devices (TRD)
- Mandibular advancement devices (MAD)
- Continuous Positive Airway Pressure (CPAP)
- Nasal products
- Anti-snoring pillow
- Chin Straps
- Vestibular Shields
- Others
Based on the surgical procedure types, the anti-snoring device and snoring surgery market is categorized as follows:
- Uvulopalatopharyngoplasty (UPPP)
- Laser-assisted uvulopalatoplasty (LAUP)
- Tonsillectomy
- Radio-frequency ablation or somnoplasty
- Palatal stiffening operations (CAPSO)
- Radiofrequency Turbinate Reduction (RFTR)
- Pillar procedures
- Others
Geographically, the anti-snoring device and snoring surgery market are best understood by segmenting it into five major regions and five major region-level markets, as follows:
-
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America Middle East, and Africa
- Brazil
- Mexico
- rest of Latin America
- Middle East and Africa
- Rest of the Middle East and Africa
The market size and forecast for each considered geographical market for the period 2015-2025 are presented, along with CAGRs for the forecast period 2017-2025, and are further cross-sectional presented in terms of the type of devices, type of surgeries, and constituent region/country level markets.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global anti-snoring device and snoring surgery market. Competition assessment tools such as major agreements, partnerships, and collaborations, market attractiveness assessment, and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report includes a profile of key market players currently enjoying prominent positions in the anti-snoring device and snoring surgery markets. The major players profiled in this report are Medtronic plc, AccuMED Corp., GE Healthcare, Koninklijke Philips N.V., Fisher & Paykel Healthcare, Apnea Sciences Corporation, ImThera Medical, Inc., ResMed, Inc., SomnoMed, MPowrxTM Health and Wellness, Sleeping Well, LLC, The Pure Sleep Company, OSIRIS SAS, ZYPPAH, and others.
Surgical interventions for snoring treatment are undergone when non-invasive procedures fail to respond. Depending on the surgery types, the anti-snoring devices and snoring surgery market are classified as follows:
- Uvulopalatopharyngoplasty (UPPP)
- Laser-assisted uvulopalatoplasty (LAUP)
- Tonsillectomy
- Radio-frequency ablation or somnoplasty
- Palatal stiffening operations (CAPSO)
- Radiofrequency Turbinate Reduction (RFTR)
- Pillar procedures
- Others
Uvulopalatopharyngoplasty (UPPP) is an invasive procedure performed to widen the airway passage by removing the uvula or the pharyngeal arches. Sometimes the tonsils or part of the palate are also removed, depending on the situation. Although it’s the most effective surgery to broaden the airway passage, the long-term complications may restrain the anti-snoring device and snoring surgery markets. The laser-assisted uvulopalatoplasty (LAUP) method, which involves removing excess tissues from the throat, is one of the less expensive alternatives to UPPP. However, the complications are fewer, but the increasing number of sessions makes it less preferable for the patient.
Radio-frequency ablation, or somnoplasty, is a minimally invasive procedure that involves radio-frequency energy to reduce the tissue surrounding the soft palate for the enlargement of the airway space. The market for somnoplasty is anticipated to grow faster in the future as the procedure takes a shorter time period and the associated complications are much lesser. A pillar procedure is done by placing an implant in order to provide structural support to the palate, which in turn keeps the airway passage open and relieves an individual from snoring. Better outcomes and little or almost no discomfort with rapid recovery make the pillar procedure preferable.
On the basis of types of devices, the anti-snoring device and snoring surgery market has been categorized as follows:
- Oral Appliances
- Tongue-retentive devices (TRD)
- Mandibular advancement devices (MAD)
- Continuous Positive Airway Pressure (CPAP)
- Nasal products
- Anti-snoring pillow
- Chin Straps
- Vestibular shields
- Others
Out of all device types available commercially in the market, oral appliances dominate the anti-snoring device and snoring surgery markets globally. Because it is a non-invasive treatment method, oral appliances are commonly used. The ease of portability, comfort, and chances of very few complications always make this segment most preferable. These mouthpieces are easily manageable and do not hinder daily work. TRD, the FDA-approved device, works by retaining the position of the tongue and inhibiting airway obstruction. MAD creates some space for airflow by holding the lower jaw and tongue in the forward position. Continuous Positive Airway Pressure (CPAP) is another non-invasive treatment for snoring. Multiple mask options of the CPAP device and an improved sleep pattern after the treatment fuel the growth of the anti-snoring device and snoring surgery markets. The market penetration of new innovative products like the cordless, mask-less, hassle-free CPAP device will drive the anti-snoring device and snoring surgery markets in the forecasting period as well. The advantage of getting reimbursed drives the oral appliance and CPAP markets to grow rapidly. However, mask discomfort, nasal congestion, and the nature of being cumbersome are a few of the factors limiting the growth of the anti-snoring device and snoring surgery markets.
Nose strips, nostril cones, or nose clips are some of the nasal products available on the market for the treatment of snoring. The easily wearable properties and cost-effectiveness of nasal products increase their usage. Anti-snoring pillows and chin straps are two non-invasive and more effective devices for snoring treatment as compared to nasal products, as no side effects are associated with these devices.
By geography, the global anti-snoring devices and snoring surgery market are cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
Geographically, North America is predicted to be the leading market for anti-snoring devices and snoring surgery, followed by Europe. A growing geriatric population is driving the anti-snoring device and snoring surgery market to grow. There is a constant rise in obesity in North America as a result of a constantly changing lifestyle. As per the statistics from the Centers for Disease Control and Prevention (CDC), around 36% of the U.S. population is suffering from obesity. This rising trend of obesity contributes largely to the snoring problem and, in turn, drives the growth of the anti-snoring device and snoring surgery markets. The healthcare expenditure in R&D for anti-snoring product innovation is expanding, which is predicted to positively influence the anti-snoring device and snoring surgery markets. Smoking and drinking habits, which are common not only among adults but also among the younger generation, are one of the leading causes of snoring. The increased health awareness among the public will hence increase the acceptance and adoption of new technology related to anti-snoring devices, which augments growth in the anti-snoring and snoring surgery markets.
Increasing health awareness among the public and developing healthcare infrastructure are driving the anti-snoring device and snoring surgery market to grow in this region. Although financial constraints may restrain the market, oral appliances have been estimated to play a major role in the anti-snoring device market in the Asia-Pacific region. However, it is anticipated that the developments in research and healthcare awareness promotion will positively affect the market in the near future.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The detailed regional classification of the global anti-snoring device and snoring surgery market is as follows:
- North America (U.S. and Canada)
- Europe (Germany, U.K., France, Spain, Italy, and the Rest of Europe)
- Asia Pacific (China, India, Japan, and the Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East and Africa (GCC plus the rest of the Middle East and Africa)
